Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP212430.RAVgmIMsaqok4_HrW_ibKeHBrpL_8HKEpzjQoRz6x1HAs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP212430.RAVgmIMsaqok4_HrW_ibKeHBrpL_8HKEpzjQoRz6x1HAs130_assertion type Assertion NP212430.RAVgmIMsaqok4_HrW_ibKeHBrpL_8HKEpzjQoRz6x1HAs130_head.
- NP212430.RAVgmIMsaqok4_HrW_ibKeHBrpL_8HKEpzjQoRz6x1HAs130_assertion description "[These findings suggest that intranasal insulin administration may have therapeutic benefit without the risk of peripheral hypoglycemia and provide further evidence for apolipoprotein E (APOE) related differences in insulin metabolism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP212430.RAVgmIMsaqok4_HrW_ibKeHBrpL_8HKEpzjQoRz6x1HAs130_provenance.
- NP212430.RAVgmIMsaqok4_HrW_ibKeHBrpL_8HKEpzjQoRz6x1HAs130_assertion evidence source_evidence_literature NP212430.RAVgmIMsaqok4_HrW_ibKeHBrpL_8HKEpzjQoRz6x1HAs130_provenance.
- NP212430.RAVgmIMsaqok4_HrW_ibKeHBrpL_8HKEpzjQoRz6x1HAs130_assertion SIO_000772 15964100 NP212430.RAVgmIMsaqok4_HrW_ibKeHBrpL_8HKEpzjQoRz6x1HAs130_provenance.
- NP212430.RAVgmIMsaqok4_HrW_ibKeHBrpL_8HKEpzjQoRz6x1HAs130_assertion wasDerivedFrom lhgdn-20090331 NP212430.RAVgmIMsaqok4_HrW_ibKeHBrpL_8HKEpzjQoRz6x1HAs130_provenance.
- NP212430.RAVgmIMsaqok4_HrW_ibKeHBrpL_8HKEpzjQoRz6x1HAs130_assertion wasGeneratedBy ECO_0000203 NP212430.RAVgmIMsaqok4_HrW_ibKeHBrpL_8HKEpzjQoRz6x1HAs130_provenance.